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 In this study 143 V. vulnificus isolates of clinical and environmental origin, were 
examined for growth on differential media, identified to species and tested for antibiotic 
resistance. A multiplex PCR was created and optimized, and phylogenetic analysis was 
conducted. The first objective was to compare phenotypic methods to identify V. 
vulnificus. Colony colors of confirmed V. vulnificus isolates on selective media (Vibrio 
vulnificus agar, thiosulfate citrate bilesalts sucrose agar, CHROMAgar Vibrio (CAV), 
and colistin polymyxin B cellobiose agar), mostly matched those characteristic of V. 
vulnificus. To test the ability of these media to select for V. vulnificus, new presumptive 
V. vulnificus isolates were collected and grown on the four media. Most of the tested 
media had very high false positive rates, with isolates not confirmed as V. vulnificus 
through PCR of the vvhA gene, growing with characteristic V. vulnificus colony colors. 
CAV was determined to be the most differential. The Biolog Microbial Identification 
System was used to identify V. vulnificus isolates and had a 96% correct identification 
rate.  Antibiotic resistance of  V. vulnificus isolates was assessed and compared with 
isolate origin. Almost all the V. vulnificus isolates were susceptible to all the antibiotics 
used. Only five isolates displayed any type of resistance and thus no relationship with 
origin could be established. A multiplex PCR protocol using amplification of vvhA and 
the 16S gene was developed, optimized, and tested to identify an isolate as V. vulnificus. 
Buffer optimization was simultaneously conducted and TBE was determined to be the 
most effective buffer for gel electrophoresis with the produced amplicons. Finally, a 
fragment of the vvhA gene from each isolate was sequenced. Analysis of the fragment 
resulted in phylogenetic trees with two distinct branches related to clinical or 
 xi 
environmental isolates. Virulence factors associated with the constructed phylogeny but 
isolate origin did not. This study was conducted to further characterize a group of well-
studied V. vulnificus isolates and to find methods to differentiate clinical from 
environmental isolates. Continued analysis of these and additional isolates may further 
our knowledge of the species and reveal more characteristics indicative of pathogenicity. 
 
INTRODUCTION 
 V. vulnificus is a Gram negative, halophilic bacterium that ferments lactose 
(Hollis et al. 1976). Among vibrios, the ability to ferment lactose is unique to V. 
vulnificus and led to its speciation. However, a sub population (~15%) of V. vulnificus 
lacks the ability to ferment lactose (Oliver 2005), including all biotype III strains 
(Zaldenstein et al. 2008). The first isolate recovered from an infected patient in 1976 
(Hollis et al. 1976) was not named and was referred to as a lactose-positive Vibrio. Later 
the same year it was named Beneckea vulnificus (Reichelt et al. 1976) and in 1979 it was 
renamed and classified as V. vulnificus (Farmer 1979). Isolates are now identified as V. 
vulnificus by the presence of the Vibrio vulnificus hemolysin A (vvhA) gene and are 
placed into one of three biotypes (I, II, or III) (Johnson et al. 2012).  
 Vibrio vulnificus is a human pathogen with ~50% mortality rate from food borne, 
and ~22% mortality rate from cutaneous infections (Oliver 2013). V. vulnificus is found 
in warm brackish waters around the world. Isolates have been recovered from coastal 
areas along the Atlantic, Pacific and Gulf Coasts of the U. S. (Oliver 2005), Europe 
(Dalsgaard  et al. 1999), Israel (Zaldenstein et al. 2008), and several East Asian countries 
(Oliver 2005). The threat to humans is compounded by the fact that V. vulnificus is often 
associated with invertebrates (oysters, shrimp, etc.) that are consumed by humans (Hollis 
et al. 1976; CDC 2013a). Vibrios, such as V. vulnificus, also pose a threat to commercial 
aquaculture as they are fish and crustacean pathogens (Molina-Aja et al. 2002; Horseman 
and Surani 2010; Kitiyodom et al. 2010).  Several invertebrates, including shrimp and 
oysters, that are farmed commercially, are at risk of infection (Molina-Aja et al. 2002), 




health is also at risk through consumption of infected products. Of all seafood borne 
illnesses in the U. S., V. vulnificus causes the most infections and has the highest 
mortality (Oliver 2005). Most human infections result from eating contaminated seafood; 
primarily oysters and other shellfish. Despite the widespread occurrence of this pathogen 
in water and seafood, less than 100 infections occur per year in the U. S. In 2012 there 
were 35 deaths nationwide, with the majority of cases occurring along the Gulf Coast 
(CDC 2013a).  However, the incidence of infections has been increasing since 1996 
(CDC 2013b).  A study on vibriosis was conducted by Newton et al. (2012) in which data 
from the Centers for Disease Control and Prevention (CDC), Cholera and Other Vibrio 
Illness Surveillance, and Foodborne Diseases Active Surveillance Network were 
compiled. They concluded that from 1996 to 2010 the overall incidence of vibriosis has 
approximately tripled while V. vulnificus infections increased from 0.01 to 0.05 per 
100,000 people (Newton et al. 2012).  
 In addition to genotypic differences, specific phenotypic assays have been used to 
differentiate strains. Distinct requirements for growth, such as temperature, salinity, and 
pH ranges, and substrate utilization vary between biotypes (Bisharat et al. 1999; Chase 
and Harwood 2011). With the severity and rapid progression of infections caused by this 
organism, antibiotic resistance is another important phenotypic characteristic. Biotypes I 
and III are known to cause human infections, while biotype II is primarily an eel 
pathogen (Horseman and Surani 2010). Most cases of human infections result from 
biotype I strains and infections caused by biotype III have been limited to Israel 
(Zaldenstein et al. 2008). Each biotype is distinguished by different metabolic profiles 




parameters (for example, biotype 2 strains cannot grow at 42°C) (Oliver 2005). Chase 
and Harwood (2011) reported that V. vulnificus biotype I isolates grew rapidly, and 
preferred a temperature of 37°C, salinity of 2.5% and pH of 7.0 which are close to human 
physiological conditions, whereas biotypes II and III grew significantly more slowly, 
under all conditions, compared to biotype I.  Oliver (2005) described differences between 
biotypes including the ability of biotype 1 to grow at 42°C. Biotype III isolates differ 
from the other two in that they lack the ability to ferment lactose and cellobiose (Bisharat 
et al. 1999). However, identifying definitive characteristics, that can be used to 
differentiate pathogenic and non-pathogenic strains, has met with little success, due to the 
variability within the species (Sanjuán et al. 2009). 
V. vulnificus strains can also be grouped into clinical (C) and environmental (E) 
genotypes based on several housekeeping genes which are involved in basic cellular 
maintenance (chaperonin, uridine monophosphate kinase, RNA polymerase σ70 factor, 
glutamine synthetase, and gyrase B and DNA repair (recA) (Rosche et al. 2010; Oliver 
2013) or the virulence correlated gene (vcg) (Rosche et al. 2010; Bier et al. 2013). 
Polymorphisms in the 16S rRNA gene were used by Nilsson et al. (2003) to correlate 
pathogenic isolates with a genotype of B and non-pathogenic with A and AB.  
   
VIRULENCE OF V. VULNIFICUS 
 Not all V. vulnificus isolates cause disease and much attention has been focused 
on identifying virulence factors associated with human infections. High iron 
concentration in blood, possibly due to liver dysfunction/alcoholism, has been identified 




in blood combined with the ferrophilic nature of V. vulnificus contribute to the virulence 
of the species. Biotype I isolates, in particular, take advantage of the replete nutrients 
(such as iron) and when combined with rapid doubling time, can overwhelm the host 
(Kim et al. 2006; Chase and Harwood 2011).  
There are a number of other characteristics that have been linked with virulence 
of V. vulnificus such as the ability to ferment mannitol (Drake et al. 2010). Sialic acid is 
abundant in the human digestive tract and the ability to metabolize it may also be linked 
with virulence (Bier et al. 2013); strains not capable of metabolizing sialic acid exhibited 
decreased virulence in mice (Jeong et al. 2009). Type IV secretion systems have been 
identified as virulence factors in several bacteria (Cascales and Christie 2003) and a 
polymorphism in the type IV secretion system has been identified as a putative virulence 
factor in V. vulnificus (Roig et al. 2010). Bier (2013) clustered V. vulnificus isolates based 
on several genes including putative virulence factors and markers and observed that 
mannitol fermentation, pilF, 16S type B, vcg C, and the sialic acid metabolizing gene 
nanA clustered together in group IIA. However, there was much variation in the 
presence/ absence of virulence factors across all groups. Capsules have been associated 
with virulence in some bacteria including V. vulnificus. Typically, capsule positive 
colonies of V. vulnificus appear opaque, with a smooth or rugose surface (Garrison-
Shilling et al. 2011), while capsule negative strains appear translucent and smooth on 
laboratory media. In addition to capsule presences, phase variation of capsules in V. 
vulnificus is common, resulting in numerous different types of capsules that can be 
expressed within a population (Hilton et al. 2006). Hilton et al. (2006) discovered a 




significantly longer in the lab to lose their capsules than E genotypes. Other phenotypic 
differences between clinical and environmental isolates could be used for rapid 
identification of potentially pathogenic V. vulnificus. 
 
PHENOTYPIC IDENTIFICATION AND DIFFERENTIATION OF                        
V. VULNIFICUS STRAINS 
Substrate Utilization 
 Identification of V. vulnificus from environmental samples is often conducted 
using selective and differential agars from which colonies with appropriate color and 
morphology are isolated. Vibrio vulnificus agar (BAM Media M190: Vibrio vulnificus 
Agar (VVA) 2013) selects for V. vulnificus through an elevated pH and a single carbon 
source: cellobiose. V. vulnificus has the ability to ferment cellobiose and colonies appear 
on VVA as a yellow “fried egg” colony with a yellow halo (Kaysner and DePaola 2004). 
CHROMagar™ Vibrio (CAV), colistin polymyxin B cellobiose plus (CPC+), and 
thiosulfate citrate bile salts sucrose agar (TCBS) are also commonly used for rapid 
isolation and phenotyping of V. vulnificus (Williams et al. 2013). Both VVA and CPC+ 
contain cellobiose as the sole carbon source which when fermented results in a color 
change of the medium, differentiating potential V. vulnificus isolates from other bacteria. 
CPC+ also contains the antibiotics colistin and polymyxin B which inhibit the growth of 
non-target organisms. CAV uses a blend of proprietary chromogenic compounds to 
differentiate species based on color; V. vulnificus turns turquoise. TCBS contains 
inhibitory salts and is selective for Vibrio spp. but has limited species differentiation 




al. (2013) in which environmental samples are initially isolated on CAV and turquoise 
colonies are then spotted on CPC+ and TCBS. Colonies of the appropriate color on both 
types of media (yellow and green respectively) can then be presumptively identified as V. 
vulnificus with a 93% confirmation level by PCR (Williams et al. 2013).  
 Additional selective and differential media for V. vulnificus have been proposed 
and compared in an attempt to simplify and optimize recovery of isolates. Cerdá-Cuéllar 
(2001) compared cellobiose colistin agar (CC), Vibrio vulnificus medium (VVM), VVMc 
(VVM without polymyxin), and TCBS for positive identification of V. vulnificus. VVMc 
and VVM had 53% and 49% positive identification rates while CC and TCBS had 47% 
and 42% positive identification rates respectively (Cerdá-Cuéllar et al. 2001).   Vibrio 
vulnificus X-Gal (VVX) has also been proposed as a selective and differential medium in 
which the antibiotics colistin and polymyxin B select for V. vulnificus and lactose 
fermentation causes V. vulnificus colonies to turn blue (Griffitt and Grimes 2013).  
Various media, alone or in combination, have been tested for quick screening of 
V. vulnificus in environmental samples. Froelich et al. (2014) tested the efficiency of 
CPC+, CAV, VVX, and the triple plating method, developed by Williams et al.  (2013), 
for recovering V. vulnificus from environmental samples and eliminating false positives 
and negatives. VVX had the highest correct identification percentage at 81% of 
presumptive V. vulnificus colonies (confirmed by PCR amplification of vvhA), followed 
by CAV at 74% and CPC+ at 44%. The triple plating method had a 68% correct 
identification rate; lower than the 93% reported by Williams et al. 2013. The discrepancy 
was due to a high false negative rate because of isolates that fermented sucrose on TCBS 




rate was 7% with the triple plating method and the next lowest rate was 15% with VVX 
(Froelich et al. 2014). Despite the usefulness of the media for isolating V. vulnificus from 
environmental samples, the problem of differentiating potentially pathogenic populations 
remains. Further characterization of carbon sources that can be used by certain strains of 
V. vulnificus may lead to the creation of new differential media for clinical and 
environmental isolates.  
 
Antimicrobial Resistance 
Antibiotic resistance has important ramifications for both the medical community 
and industry.  With growing use of antibiotics to treat infections in aquaculture, antibiotic 
resistance in V. vulnificus has increased (Li et al. 1999; Kitiyodom et al. 2010).  
Currently the Centers for Disease Control and Prevention recommend doxycycline and a 
third generation cephalosporin or a fluoroquinolone to treat human infections (CDC 
2013a) while oxytetracycline, enrofloxacin, sarafloxacin, trimethoprim sulfamethoxazole, 
chloramphenicol, gentamicin, and florfenicol are used in aquaculture (Roque et al. 2001; 
Cabello et al. 2013). Antibiotic susceptibility profiles can be developed for isolates and 
may be able to be used to differentiate between clinical and environmental strains as well 
as origin. A survey of literature has found that many isolates were either susceptible to 
most antibiotics tested or were resistant to multiple antibiotics (Han et al. 2007; Kim et 
al. 2011). Such variability may be due to regional differences, time of the year, tested 
antibiotics, or sample size. However, some large studies (n>100) have failed to find 
widespread antibiotic resistance at the tested location (Han et al. 2007; Roig et al. 2009). 




selected antibiotics and the number included in studies. Researchers in different 
countries, as well as in smaller regions, have chosen antibiotics that may be relevant only 
for their area, such as those used nearby in agriculture. Such variability complicates 
comparison of antibiotic resistance in the V. vulnificus population. Additionally, 
variability in drug panel size limits results comparison when the drug panel is small or 
not balanced.  Currently CLSI M45-A2 lists a recommended drug panel for V. vulnificus 
that includes frequently used drugs and those used to treat infected humans. However, a 
larger common drug panel would aid between-study comparisons.  
  
GENOTYPIC IDENTIFICATION AND DIFFERENTIATION OF V. 
VULNIFICUS STRAINS 
Genetic analyses have been useful for differentiating bacterial species as well as 
strains. Typically the 16S gene is used to distinguish species of bacteria and group them 
based on their relatedness. However, differences in species specific genes have enabled 
subspecies classifications. For example, Nilsson et al.  (2003) discovered that clinical and 
nonclinical V. vulnificus strains could be differentiated by a 16S polymorphism. Type A 
and AB isolates were typically not of clinical origin while type B were recovered from 
patients (Nilsson et al. 2003). The virulence correlated gene E (vcgE) (environmental) 
and C (vcgC clinical) have also been identified as markers for non-pathogenic (E) and 
pathogenic (C) V. vulnificus (Rosche et al. 2005). The vcgE and vcgC polymorphisms 
were later correlated with other distinct differences in housekeeping genes between 
isolates of environmental and clinical origin (Rosche et al. 2010). Multilocus sequence 




2005). Mahmud et al. (2010) recently used Rep PCR to group isolates recovered from 
aquaculture into clinical and environmental classes. 
 
PHYLOGENETIC DIFFERENTIATION OF V. VULNIFICUS STRAINS 
 The advent of DNA sequencing and polymerase chain reaction (PCR) has enabled 
researchers to identify bacterial species without the need for culturing. Amplification and 
sequencing of 16S genes has led to differentiation of species and has been used to 
determine species relatedness. However, obtaining sequence data is a two-step process, 
amplification and then sequencing, which can take days to complete. For faster 
identification of a species, amplification of unique species specific genes, such as vvhA in 
V. vulnificus, can be performed. PCR product can be visualized by gel electrophoresis (or 
fluorescence for real time PCR) and presence of a product of the appropriate size, 
indicates a positive reaction. After identification, PCR products can then be sequenced 
and compared to one another using many different phylogenetic techniques. 
 An important first step in phylogenetic analysis is sequence alignment. Multiple 
sequence alignments can be performed by tools such as Clustal Omega, Clustal X, 
MUSCLE, etc. (www.ebi.ac.uk/Tools/msa). Each program utilizes a different alignment 
strategy, potentially resulting in different phylogenies. It has been shown that alignment 
strategy has an effect on tree topology (Wong et al. 2008) and therefore, careful choice of 
alignment program is necessary. 
 Step two for constructing phylogenetic trees is to choose a tree building strategy, 
such as neighbor joining, maximum likelihood analysis etc. Neighbor joining was 




minimal evolutionary steps but it does not attempt to make the most parsimonious tree as 
in maximum parsimony (Saitou and Nei 1987). Neighbor joining has the advantage of 
speed compared to other programs (maximum parsimony and maximum likelihood) and 
usually produces a tree with the correct topology (Saitou and Nei 1987; Tateno et 
al.1994). Maximum likelihood analysis of DNA sequences began in 1981 when Joseph 
Felsenstein developed a program to process DNA sequences (Felsenstein 1981). At its 
most basic the maximum likelihood method uses all sequence data to find the most 
probable phylogenetic tree. To do this, the algorithm assumes that all changes to DNA 
are independent of one another. The first sequence in the alignment file is used as the 
starting point and each subsequent sequence is added and placed on the tree. Before each 
new sequence is added, the algorithm maximizes the likelihood of placement and branch 
length. As the tree grows, sequences are rearranged after each addition and the tree with 
the highest likelihood is selected and the process repeats until all sequences have been 
added (Felsenstein 1981). Due to the algorithm constantly modifying the tree and 
calculating the maximum likelihood of each addition the process is time and 
computationally intensive. However, the maximum likelihood method can produce more 
accurate trees than other methods and includes information that can be used for statistics. 
Some drawbacks to the maximum likelihood are that the order of sequences in the 
alignment file can have an effect on tree topology, as they are read in the order they 
appear, and the algorithm considers all changes to be independent of one another which is 
known to be false (Felsenstein 1981).  
 After a phylogenetic tree has been constructed, the next step is to determine how 




determine confidence in phylogenetic trees and was first used by Felsenstein (1985) to 
determine the confidence of species relatedness. The process involves replicating the 
original set of sequences in an alignment file and modifying characters in each sequence 
(bases for DNA) at random. This process is repeated a large number of times (as 
specified by the user) where each modified sequence represents a new "sample." By 
increasing the number of "samples" a more accurate estimate of relatedness can be 
determined (ie 2000 resampling events would be more accurate than 100). Each modified 
sample set is used to construct a phylogenetic tree (using any of the previously described 
methods). All of the constructed trees can then be combined into a consensus tree where 
the arrangement is determined by the most common arrangements in the group of trees.  
 
OBJECTIVES OF THIS STUDY 
1. Compare several phenotypic methods to identify V. vulnificus, including use of 
selective media and the Biolog Microbial Identification System. 
2. Assess several methods for their ability to differentiate the origin of V. vulnificus 
isolates (clinical vs. environmental), including antibiotic resistance profiles, 
appearance on selective media, and phylogeny. 
3. Use phylogenetic analysis of a fragment of the vvhA gene to determine if putative 









V. VULNIFICUS ISOLATES  
 One hundred and forty two confirmed (by detection of the vvhA gene using PCR)   
V. vulnificus cultures were provided by the National Oceanic and Atmospheric 
Administration (NOAA), from multiple sources (including state health laboratories, FDA 
etc.) and including both clinical and environmental source isolates (Table 1). Clinical 
isolates were originally obtained from state and federal agencies while environmental 
isolates were collected from water, sediment, and oysters (Supplementary table 1) 
(Moore and Mott 2013). Some phenotyping and genotyping analyses had been previously 
conducted on these isolates (including but not limited to: pilF, mannitol fermentation, and 
heavy metal resistance) (Diaz and Mott 2012; Moore and Mott 2013; Shi et al. 2012). 
One additional confirmed V. vulnificus isolate collected during this study was included, to 
make a total of 143 confirmed V. vulnificus isolates.  An additional ~80 isolates, 
presumptively identified as V. vulnificus by selective media, were collected from 
residential and commercial aquaria, and coastal Virginia sites: Colonial Beach, VA, and 















Table 1. Origin of clinical and environmental V. vulnificus isolates used in this study. 
  





Oregon Virginia Total 
Clinical 3 14 4 37 0 0 0 0 58 
Environmental 0 0 2 31 49 1 1 1 85 
          143 
 
Sample Collection 
 Water samples were collected on August 25, 2013 from Virginia Beach, VA at a 
depth of ~10cm with a water temperature of 24.4°C for sample one, 24.0°C for sample 
two, and 27.5°C for sample three. A sample of water from Colonial Beach, VA was 
collected on September 7, 2013 with a water temperature of 26.5°C and depth of ~10cm. 
Water from local saltwater aquaria was collected at three different locations: a home 
aquarium (sample collected on September 9, 2013 with a water temperature of 26.5°C), a 
commercial aquarium at a pet store (water from a single tank collected on September 24, 
2013), and two water samples were collected from two separate aquaria at a different 
commercial pet store (on September 24, 2103). At the first commercial pet store, all 
aquaria were linked by a re-circulating water filtration system. Temperature of water 
samples could not be measured at the time of collection at the pet stores. Water samples 
at Virginia Beach, Colonial Beach, and home aquaria were collected by opening a sterile 
plastic bottle below the surface of the water, allowing the bottle to fill, and then capping 
the bottle under water. Water samples from local pet stores were acquired by staff that 
scooped out water from tanks and poured it into bags. Samples were transported to the 






 Water samples were processed as follows: sterile vacuum apparati were set up 
with 0.45um nitrocellulose filters (Sartorius Stedim, Bohemia, New York); ~4ml of 
sterile phosphate buffered saline (PBS) was used to wet each filter. Volumes of 0.5, 1, 
and 2ml of sample were filtered.  The sides of each vacuum funnel were then rinsed with 
the PBS solution (~3ml sprayed onto the sides in a circular motion) three times. Using 
sterile forceps, each filter was removed and placed onto Vibrio vulnificus agar (VVA) 
plates. The plates were incubated at 35°C overnight. Yellow colonies were transferred to 
a new VVA plate and incubated. Individual yellow colonies on these plates were selected 
and used to inoculate tryptic soy broth (TSB) (Becton, Dickinson and Company, Franklin 
Lakes, New Jersey) supplemented with NaCl (Merck, Whitehouse Station, New Jersey) 
to a final concentration of 2% NaCl; these tubes were incubated at 35°C. Newly collected 
isolates were identified by numbers starting at 269. 
 
Culture Maintenance 
 All cultures were maintained on Tryptic Soy Agar (TSA) (Becton, Dickinson and 
Company) supplemented with NaCl to a final concentration of 2% NaCl. Slants were 
prepared by adding 6ml of TSA to capped culture tubes (~15ml volume). After 
solidifying, they were inoculated with a loop full of broth culture, incubated, and stored 
at room temperature (~22°C) for up to one month. In addition, isolates were stored (up to 
six isolates per TSA plate, depending on the growth characteristic of the isolate) at room 
temperature. Each culture was transferred, by selecting an individual colony, every six to 




contamination was observed, isolates were streaked for re-isolation on CHROMAgar 
Vibrio (CHROMagarTM, Paris, France) (CAV)/ colistin cellobiose polymyxin B (CPC+)/ 
or thiosulfate citrate bile salts sucrose (TCBS) agar.  
 
Culture Preservation 
 All isolates were preserved for long term storage by preparing broth cultures and 
immediately cryogenically preserving them. Broth cultures were prepared by inoculating 
5ml of TSB supplemented with NaCl to 2%. Cultures were placed in a rotary incubator at 
35°C overnight.  To each cryo vial, 0.5ml of a fresh overnight broth culture was added 
together with 0.5ml of a 70% TSB/30% glycerol (Amresco, Solon, Ohio) solution. Tubes 
were mixed briefly and then placed into a -80°C freezer. 
 
Culture Activation from Cryogenically Frozen Stock  
 Isolates that could not be recovered from room temperature slants were grown 
from cryogenically frozen stock cultures. Up to a maximum of ten isolates were removed 
from the freezer at one time (to ensure cultures did not thaw). A sterile 100ul pipette tip 
was used to scrape off a portion of frozen bacteria, which was then used to inoculate a 
CAV or TCBS plate (NOAA isolates <268) or VVA or TCBS plate (isolates 269<) or 
TSA plate (isolates that failed to grow on CAV, TCBS, or VVA), and incubated. Isolates 
were checked for abnormalities in colony morphology and streaked for isolation onto 
CAV, VVA, TCBS, or CPC+ plates. Each individual colony was then streaked onto TSA 






Growth on Selective Media 
 The following media were prepared: VVA (BAM Media M190: Vibrio vulnificus 
Agar (VVA) 2013), CPC+ modified from Warner and Oliver (2007), CAV 
(CHROMagarTM), and TCBS (Becton, Dickinson and Company). CPC+ was prepared 
according to Warner and Oliver (2007) except CPC base (Sigma-Aldrich) was used. The 
media was comprised of CPC base medium (Sigma-Aldrich) and 900ml distilled water 
(solution A). Solution B contained: 4g MgCl2 6H2O (Amresco), 4g KCl (Merck), 0.0781g 
colistin methanosulfonate (MP Biomedicals, Santa Ana, California) (1*106 units), and 
0.0667g polymyxin B (Enzo Life Sciences, Farmingdale, New York) (4*105  units) all 
dissolved, by gentle heating, in 100ml distilled water. Solution B was filter sterilized 
before being added to solution A at a ratio of 100ml solution B per 900ml of solution A. 
VVA (BAM Media M190: Vibrio vulnificus Agar (VVA) 2013) consisted of solution one 
and two. Solution one consisted of:  20g peptone (Becton, Dickinson and Company), 30g 
NaCl, 10ml dye stock (0.6g bromothymol blue (Harleco, Hartman-Leddon Company) 
and 100ml 70% ethanol), and agar 25g (Becton, Dickinson and Company). Solution two 
consisted of 10g of cellobiose (Alfa Aesar, Ward Hill, Massachusetts) dissolved in 100ml 
distilled water with gentle heat. Solution one was brought to a boil and 10M NaOH was 
added to bring the pH up to 8.2+ 0.2. After being autoclaved for 15min at 121°C, solution 
one was allowed to cool and solution two was filter sterilized and added to solution one 
and plated. CAV and TCBS (Becton, Dickinson and Company) were prepared according 
to the manufacturer’s instructions. Isolates were streaked onto each type of medium and 




visually and imaged with a Biomic V3™ system (Giles Scientific, Santa Ana, 
California). Some color changes were only visible when examined manually and were 
not present or were distorted when imaged. Incomplete color changes (some yellow or 
green) were subjectively determined to be more yellow or green. Control cultures of V. 
vulnificus (PCR confirmed isolate) and V. parahaemolyticus (ATCC 17802) were used to 
test all chromogenic media for colony color.   
 
Biolog Microbial Identification System (Biolog MIS) 
 All isolates were analyzed using the Biolog MIS (Biolog, Hayward California) to 
confirm their identification by a phenotypic method. Procedures followed the 
manufacturer's instructions for Biolog GEN III Microplate™ (Biolog, Hayward 
California).  Briefly, isolates were first grown on TSA plates overnight at 35°C and then 
were streaked on BUG+B agar and incubated at 33°C for 18-24h. Isolates that were taken 
from long term storage were streaked on TSA twice before analysis, as per 
manufacturer's instructions. Using Inoculatorz™ (Biolog, Hayward California), bacteria 
were suspended in inoculating fluid-B (IF-B) (presumptive V. vulnificus) or IF-A for 
control cultures and V. parahaemolyticus ATCC 17802) to a turbidity in the range of 
0.90-0.98.  The inoculating fluid was then transferred to a reservoir and, using an eight 
lane pipettor, 100ul of sample was pipetted into each well of a 96 well plate. Plates were 
incubated at 33-35°C for 20-26h and then read using the Biolog Microplate™ reader 
(Biolog, Hayward California). The lid of each 96 well plate was removed and the bottom 
cleaned with a Kim Wipe before being read. For isolates that were not identified to a 




there was no identification or were not identified as V. vulnificus were re-analyzed to 
confirm the results. Staphylococcus epidermidis ATCC 12228, E. coli ATCC 11775, 
Paenibacillus polymyxa ATCC 842, and Stenotrophomonas maltophilia ATCC 13637 
were used as controls.  
 
Antibiotic Resistance Analysis (ARA) 
 One hundred forty two previously collected isolates (Moore and Mott 2013) and 
one additional isolate, collected during this study, were confirmed to be V. vulnificus by 
PCR amplification of the vvhA gene (Panicker and Bej 2005) and then subjected to 
antibiotic resistance analysis. A comprehensive literature survey was conducted to 
determine the most common antibiotics used when screening V. vulnificus for antibiotic 
resistance. 'Instances of resistance' was calculated based on the number of studies that 
found at least one isolate that was resistant to the specified antibiotic. To determine how 
frequently antibiotic resistance to a particular drug occurred, 'Instances of use' was 
included; in which the number of studies including the drug were totaled. A twelve drug 
panel for testing the V. vulnificus isolates was constructed based on the findings of the 
literature search, including CLSI M45-A2 recommendations (CLSI 2010) (Table 2). Ten 
classes of antibiotics were included along with a beta-lactam and beta-lactamase inhibitor 
combination. The drugs selected have been used frequently in V. vulnificus antibiotic 
resistance analysis tests which allows cross study comparisons. Additionally, drugs used 







Table 2. Antibiotic drug panel used for antibiotic resistance analysis. 
Antibiotic Abbreviation Class 
   
Ampicillin AM Penicillin 
Piperacillin-tazobactam TZP Beta-lactam+beta-lactamase inhibitor 
Gentamicin GM Aminoglycoside 
Tetracycline TE Tetracycline 
Cefepime FEP Cephalosporin 4th gen 
Trimethoprim-sulfamethoxazole SXT Folate pathway inhibitor 
Meropenem MEM Carbapenem 
Imipenem IPM Carbapenem 
Ceftriaxone CRO Cephalosporin 3rd gen 
Chloramphenicol C Amphenicol 
Amikacin AN Aminoglycoside 
Ciprofloxacin CIP Fluoroquinolone 
 
 Antibiotic resistance analysis was conducted strictly according to the Clinical and 
Laboratory Standards Institute’s guidelines in M45-A2 (2010). Briefly, for each isolate, 
TSA was inoculated and incubated overnight at 35°C, and then enough bacteria were 
suspended in 0.85% saline to reach an OD600 between 0.08-0.1. In a biosafety cabinet, a 
sterile cotton tipped applicator was dipped in the saline solution and used to inoculate a 
150mm plate containing 60ml Mueller Hinton agar (MHA). Twelve commercial 
antibiotic disks (Becton, Dickinson, and Company) (Table 2) were applied to each plate 
using a disk dispenser. Plates were allowed to sit for 15min before being inverted and 
incubated for 16-18h at 35C. Control cultures of E. coli ATCC 25922 and 35218 were 
used for antibiotic disk quality control for zone diameter of typical antibiotics and ẞ-




BIOMIC® V3 image analysis system and interpreted using CLSI standards for V. 
vulnificus, with the exception that ceftriaxone susceptibility was interpreted according to 
enteric bacteria standards (as there were no guidelines for zone diameter with V. 
vulnificus). 
 
POLYMERASE CHAIN REACTION (PCR) BASED ANALYSES 
Species Identification and PCR Verification 
 To confirm that all isolates were V. vulnificus, PCR of the vvhA gene was 
conducted. Amplicons were also sequenced for phylogenetic analysis. Amplification of 
the 16S gene was included for some isolates for sequencing and as a positive control for 
DNA extraction and PCR. Also, a multiplex PCR was designed to both identify an isolate 
as V. vulnificus and confirm that the reaction was not inhibited. 
  
vvhA 
PCR to amplify the vvhA gene was conducted for all isolates utilized in this study. 
vvhA was selected as it can be used to identify V. vulnificus because it is present in no 
other species of bacteria (Wright et al. 1985). Procedures followed Panicker and Bej 
(2005) except fluorescent probes were not used, number of cycles was reduced to 30, and 
MgCl2 concentration was reduced to 15mM.  A master mix consisting of 1x PCR buffer, 
15mM MgCl2, 200uM dNTPs, 1.5U Taq polymerase (Amresco and Fisher Scientific, 
Waltham, Massachusetts), PCR grade nuclease free water (Amresco and Geno 
Technology Inc., St Louis, Missouri), and 0.4uM of each primer (F-vvh785 (5’ TTC 




GCG AAT ACG TTG 3’)) (Invitrogen) was prepared. The primers chosen were selected 
due to specificity and previous usage (Panicker and Bej 2005). Template DNA was 
extracted from 1ml of an overnight culture grown in TSB by using an UltraClean® 
Microbial DNA Isolation Kit (MO BIO, Carisbad, California) and a Biospec Mini-
Beadbeater (Bio Spec Products Inc., Bartlesville, Oklahoma). To each PCR reaction tube 
24ul of master mix was added followed by 1ul of template DNA. PCR with crude DNA 
extraction was utilized for routine analysis.  For DNA extraction, a colony was suspended 
in de-ionized water, boiled for 10min, centrifuged at 16000 x g and supernatant was used 
as the DNA template. PCR reactions with crude DNA extract utilized 22.5ul of master 
mix and 2.5ul template. More template was used due to lower concentrations of DNA. 
Cycling parameters were as follows: 94°C for 120s and 30 cycles of: 94°C for 15s, 56°C 
for 15s, and 72°C for 25s followed by an infinite hold at 4°C.  
Two percent agarose gels were prepared with 50ml of tris-borate EDTA (TBE) 
(Amresco) and 1g molecular grade agarose (Fisher Scientific). Five microliters of product 
was mixed with 2ul of 6x loading dye, placed in a well of a 2% agarose gel and run at 
6.7V/cm until the leading dye band was at 75% of the length of the gel (~30min). A 
100bp ladder (Thermo Fisher Scientific) was included along with a negative control. An 
isolate that had previously been identified a V. vulnificus was included as a positive 
control in each run and no template DNA served as the negative control. Gels were 
stained in a 0.5% ethidium bromide solution for 5min, then de-stained in distilled water 
for 1min before being imaged. A 205bp product indicated the presence of the vvhA gene 






If no PCR product was obtained from amplification of vvhA, the DNA was 
subjected to 16S PCR using BAC-8f (5’AGA GTT TGA TCC TGG CTC AG 3’) and 
Univ-1492r (5’ GGT TAC CTT GTT ACG ACT T 3’) primers (Invitrogen) (Fierer and 
Jackson 2006). PCR conditions were as follows: 1x buffer with 15mM magnesium 
chloride, 0.2mM dNTPs, 0.5uM each primer, 1.25U taq polymerase (Amresco or Fisher 
Scientific), 1ul template DNA (2.5 for crude DNA extract), and sufficient PCR grade 
water to reach 25ul final volume. Cycling parameters were as follows: 95°C 300s 
followed by 35 cycles of 95°C 60s, 50°C 30s, 72°C 90s, and a final elongation of 72°C 
for 300s followed by an infinite hold at 4°C. Gels were prepared as before except a 1kb+ 
(Affymetrix, Santa Clara, California) ladder was included. A band at 1500bp indicated a 
successful reaction.  
 
DNA Quantification 
 DNA was quantified for samples in which no vvhA product was obtained or had a 
band present on a gel that was not ~200bp. A NanoVue (General Electric Company, 
Schenectady, New York) spectrophotometer was used to quantify DNA in ng/ul based on 
its 260/280nm ratio. Approximately 1ul of DNA extract was placed in the NanoVue and 
measured, the sample was then wiped away and a new 1ul of sample was measured. If the 
measured values differed by more than 60ng/ul the procedure was repeated a third time. 
A threshold difference of 60ng/ul was used as most repeated measurements were within 
this range. Values were averaged to give a DNA concentration. DNA was diluted in 





 A multiplex PCR was created to quickly and simultaneously determine if an 
isolate was V. vulnificus, by amplification of the vvhA gene, and to confirm that the 
reaction was not inhibited by amplification of the 16S gene. Primers were screened for 
compatibility using AutoDimer (Vallone and Butler 2004) 
(http://www.basic.northwestern.edu/biotools/oligocalc.html) and no primer dimers were 
reported (Supplementary Figure 17). Next, the reaction was optimized and tested. 
 DNA extracted from V. vulnificus isolates as well as V. parahaemolyticus and E. 
coli was adjusted to 50-75ng/ul using sterile PCR grade water (Geno Technology Inc.) 
and used for all multiplex PCR reactions unless stated otherwise. Initial PCR conditions 
were as follows for 35ul reactions: 1x buffer, 1.5mM MgCl2, 0.2mM dNTPs, 0.5uM of 
primer BAC-8f, 0.5uM of primer UNIV-1492r, 0.4uM of primer vvh785f, 0.4uM of 
primer vvh990r, 1.25U taq, 1.0ul template DNA, and PCR grade water to bring up to 
volume. Cycling conditions were set to: 94°C for 300s, followed by 30 cycles of : 94°C 
for 60s, 55°C for 30s, and 72°C for 90s with a final extension of 300s at 72°C and an 
infinite hold at 4°C. Presence of 1500 and 205bp bands indicated a successful reaction 
and confirmed the species as V. vulnificus.  
 To get more equal amounts of both the 16S and vvhA amplicons, the vvhA primer 
concentration was reduced from 0.4uM to 0.2uM. MgCl2 concentration was optimized to 
increase yields. PCR reactions using the optimized primer concentration had MgCl2 
concentrations increased from 1.5 to 2.5, 3.5, and 4.5mM. 
 To simulate a real world application of the proposed multiplex reaction, a crude 




multiplex PCR was performed. The final multiplex PCR conditions used are as follows: 
1x buffer, 2.5mM MgCl2, 0.2mM dNTPs, 0.5uM of primer BAC-8f, 0.5uM of primer 
UNIV-1492r, 0.2uM of primer vvh785f, 0.2uM of primer vvh990r, 1.25U taq, 1.0ul 
template DNA, and PCR grade water to bring up to volume. Cycling conditions were set 
to: 94°C for 300s, followed by 30 cycles of: 94°C for 60s, 55°C for 30s, and 72°C for 90s 
with a final extension of 300s at 72°C and an infinite hold at 4°C. 
 
Buffer Optimization 
 While conducting gel electrophoresis under normal conditions, band resolution of 
the vvhA PCR product was not adequate and an exact size was difficult to resolve due to 
poor DNA ladder separation at low molecular weights. In an attempt to improve band 
resolution, increase band separation, and reduce gel running times a comparison of three 
common gel electrophoresis buffers was performed. Additionally, the multiplex PCR 
protocol was optimized while conducting the buffer comparison to compare the effects of 
each buffer on high (1500bp) and low (205bp) molecular weight PCR products. 
 Three buffers were prepared. For Tris acetate EDTA (TAE) one  liter of 1x TAE 
was prepared with 980ml de ionized water (DI) combined with 20ml of a 50x stock 
solution (Amresco) and mixed thoroughly. Tris borate EDTA (TBE) (1x) was prepared   
by combining  900ml DI  with 100ml of 10x TBE stock solution (Amresco) which was 
then mixed thoroughly. One liter of 20x Sodium borate (SB) (Brody and Kern 2004) was 
prepared by combining 200ml 1N NaOH and 600ml DI with  enough boric acid (Fisher 




the pH  was stable, DI was added to reach a final volume of 500ml. A working solution of 
1x SB was used during gel electrophoresis.  
 To make 1.5% agarose gels, 40ml of buffer and 0.6g genetic analysis grade 
agarose (Thermo Fisher Scientific) were mixed, and heated in a microwave until all agar 
dissolved. DI water was added to bring the volume up to 40ml as needed. Agarose was 
allowed to cool slightly before pouring into a gelbox. Gels were covered with ~2mm of 
buffer (570ml). Five microliters of PCR product was combined with 1ul of 6x loading 
dye (Affymetrix®) and placed into a well. Next, 5ul of 1kbp+ (Affymetrix®) and 100bp 
(Thermo Fisher Scientific) DNA ladders were added to their respective wells. All gel 
running times were dependent on voltage (PowerPac™ Basic) and were run at 5V/cm for 
40min, 6.67V/cm for 30min, or at 10V/cm for 23min. Gels were stained in a 0.1% 




Sequencing and Sequence Processing 
 All 143 isolates were subjected to vvhA sequencing for phylogenetic analysis and 
for several isolates, 16S rDNA was sequenced to confirm their identification. Ten 
microliters of PCR product was placed into a SimpleSeq™ (Eurofins Genomics, 
Huntsville, Alabama) tube and sent to Eurofins Genomics for standard sequencing using 
either BAC-8f or F-vvh785 primers.  
Sequence sample names in the data files were altered to include additional 
information and present it in a visually appealing and useful manner on a phylogenetic 




isolate)_ A/B/AB (16S type)_origin W/H/O/S (W=water, H=human, O=oyster, and 
S=sediment). For example isolate number 10 was of environmental origin and was type 
A so it was renamed: 10 E A W. After additional information was received from Dr. 
Moore isolates were renamed again to include the additional information as follows: 
isolate#_C/E_origin_16S type_vcg type (C/E)_pilF polymorphism (+/-)_mannitol 
fermentation (+/-). For example isolate 10 was an environmental isolate from water with 
a 16S type of A, vcgE, and was negative for the pilF polymorphism and mannitol 
fermentation so it was renamed: 10_E_W_A_E - -. 
Sequences were trimmed using the program DNASTAR® SeqMan™ Pro 
(DNASTAR Inc., Madison, Wisconsin). The 5' ends were trimmed to remove as many 
N's as possible and the 3' end was set to 180. If N's were present at the 3' end they were 
removed. However, if a TGGAAT was present the sequence was ended after the final “T” 
or within the TGGAAT sequence if it was not complete. The TGGAAT sequence was 
used as a cutoff point because it was at the 3’ end, easily identifiable, and present in 
virtually all sequences. 
The online sequence alignment tool Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/) was used to generate sequence alignments 
for PHYLIP. ClustalW2 and MUSCLE were used for maximum likelihood and neighbor 
joining analysis with MEGA. 
 
PHYLOGENETIC ANALYSIS 
 Isolates were subjected to phylogenetic analysis of a 205bp (useable sequence 




were identified as V. vulnificus. Two reference vvhA sequences from strains fj03-x2 
(GenBank accession number KC821520) and VvMBC105 (GenBank accession number 
KF255393) were included in all analyses. Both the neighbor joining (Dnadist and 
Neighbor) and maximum likelihood (Dnamlk) tools in PHYLIP 3.695 
(http://evolution.genetics.washington.edu/phylip/getme.html) were used (Felsenstein 
1989). MEGA V6.0 was also utilized for aligning sequences and constructing 
phylogenetic trees. Data were bootstrapped and used to construct phylogenetic trees. 
Dnamlk utilize the maximum likelihood approach and includes the molecular clock 
hypothesis. MEGA V6.0 was used as it can perform analyses quickly and is user friendly. 
Neighbor joining was included as it is a fast method to construct generally accurate 
phylogenies and is a common technique (Saitou and Nei 1987; Tateno et al.1994). Using 
the aforementioned tests, profiles of each isolate were made and used to differentiate 
isolates based on their genotype. 
  
Analysis with PHYLIP (V 3.695) 
 Phylogenetic analysis was performed using the maximum likelihood program 
Dnamlk which utilizes the molecular clock hypothesis (Felsenstein 2013). Dnadist and 
Neighbor were used to construct a distance matrix and neighbor joining tree respectively. 
When prompted to input seed or jumble numbers, a number was chosen randomly. 
Bootstrapping of data was conducted with 100 replicates (see Appendix for detailed step 
by step methods). 
  




Analysis with MEGA 6.0 (Tamura et al. 2013) 
The program MEGA v6.0 was used to align sequences and  construct 
phylogenetic trees using the maximum likelihood and neighbor joining methods. 
Parameters for analysis were determined by using the Find Best DNA/Protein models for 
maximum likelihood. Data were bootstrapped 1000 times for maximum likelihood and 




 All analyses were conducted on the 142 previously confirmed V. vulnificus 
isolates from a previous study (Moore and Mott 2013) and one isolate collected during 
this study for a total of 143 confirmed V. vulnificus isolates. 
 
PHENOTYPIC IDENTIFICATION 
Media Comparison  
 One hundred and forty two confirmed V. vulnificus isolates were streaked onto 
each of four selective and differential media typically used to grow V. vulnificus.  
Thiosulfate Citrate Bile Salts Sucrose Agar (TCBS) (Difco), CHROMagar™ Vibrio 
(CAV) (CHROMagar), Vibrio vulnificus Agar (VVA) (BAM Media M190: Vibrio 
vulnificus Agar (VVA) 2013), and Colistin Polymyxin B Cellobiose Agar (CPC+) 
(Warner and Oliver 2007) were utilized in the growth  and color comparison. Color on 
some plates could not be viewed properly (distorted coloration or faint color changes) 




as possible by comparing to controls. Three distinct color patterns were present. The first 
and most numerous was the typical yellow (Y), green (G), Y, turquoise (T) profile on 
VVA, TCBS, CPC+, and CAV respectively (Figure 1 and Table 3). A second profile 
consisted of Y, Y, Y, T (Table 4) and a third profile was Y, G, Y, W (Table 5) on VVA, 
TCBS, CPC+, and CAV respectively. Three isolates did not match any of these profiles 
or each other (Table 6).  
 
 
Table 3. Typical, and most commonly observed, media profile (colony colors) of V. 
vulnificus. Abbreviations are as follows: Y, yellow; G, green; T, turquoise. 
# of isolates Origin Medium 
  VVA TCBS CPC+ CAV 
65 Water Y G Y T 
53 Clinical Y G Y T 
8 Sediment Y G Y T 










Figure 1. Typical appearance of V. vulnificus on Vibrio vulnificus agar (top left), 
thiosulfate citrate bile salts sucrose agar (top right), colistin polymyxin B cellobiose agar 





Table 4. Second most common media color profile of V. vulnificus observed. 
Abbreviations are as follows: Y, yellow; T, turquoise. 
Isolate Origin Medium 
  VVA TCBS CPC+ CAV 
95 Blood Y Y Y T 
162 Water Y Y Y T 
217 Blood Y Y Y T 
220 Blood Y Y Y T 
221 Blood Y Y Y T 




















Table 5. Third most common media color profile of V. vulnificus observed. Abbreviations 
are as follows: Y, yellow; G, green; T, turquoise; W, white. 
Isolate Origin Medium 
  VVA TCBS CPC+ CAV 
24 Water Y G Y W 
104 Oyster Y G Y W 






Table 6. Other combinations of colony colors of V. vulnificus isolates observed. 
Abbreviations are as follows: Y, yellow; G, green; T, turquoise; W, white; NG, no 
growth. 
Isolate Origin Medium 
  VVA TCBS CPC+ CAV 
68 Sediment Y Y Y W 
75 Sediment Y G NG T 
101 Oyster Y Y G T 
 
 
Next, the ability of each medium to presumptively identify V. vulnificus was 
compared. All isolates grew with the characteristic V. vulnificus colors on VVA and 
TCBS. CPC+ failed to presumptively identify two isolates and CAV was unable to 
properly identify four isolates (Table 7) i.e. incorrect color for V. vulnificus or failure to 
grow. No association between isolate source (clinical and environmental) and media 
profile was apparent except for yellow on TCBS. Five out of six isolates that had the Y, 










Table 7. The ability of each medium to presumptively identify known V. vulnificus was 
assessed and relative effectiveness of each type of media was determined. Abbreviations 
are as follows: Y, yellow; G, green; T, turquoise; W, white; NG, no growth; ID, 
identification. 
  Medium 
# of isolates 
 with profile %  with profile 
 VVA TCBS CPC+ CAV   
  Y G Y T 130 91.5 
 Y Y Y T 6 4.2 
 Y G Y W 3 2.1 
 Y Y Y W 1 0.7 
 Y G NG T 1 0.7 
  Y Y G T 1 0.7 
% correct ID 100 100 98.6 97.2     





Table 8. The percentage of clinical and environmental isolates within each medium color 










 VVA TCBS CPC+ CAV    
  Y G Y T 130 40.8 59.2 
 Y Y Y T 6 83.3 16.7 
 Y G Y W 3 0.0 100.0 
 Y Y Y W 1 0.0 100.0 
 Y G NG T 1 0.0 100.0 
  Y Y G T 1 0.0 100.0 






Table 9. Presumptive identification of unconfirmed V. vulnificus isolates (identified as V. 
vulnificus by VVA) by each medium. Key: Y, yellow; G, green; T, turquoise; P, 






% of isolates 
with profile 
 VVA TCBS CPC+ CAV   
 Y G Y T 6 7.3 
 Y Y G T 2 2.4 
 Y G G T 1 1.2 
 Y Y Y W 42 51.2 
 Y Y Y P 6 7.3 
 Y Y/G V V 16 19.5 




89.0 100 87.8 11.0   
Total # 
isolates 






Biolog Microbial Identification System (Biolog MIS) 
 The 142 isolates previously identified as V. vulnificus and one new isolate 
collected in this study were analyzed using the Biolog MIS, Generation III 
Microplates™. Biolog MIS was able to correctly identify 137/142 (96%) of the 
confirmed V. vulnificus isolates at a confidence level greater than 0.5. Three isolates 
(Isolate #10, 71, and 163: all of environmental source) returned a “no identification” and 




source) and Photobacterium damselae (Isolate #28: environmental source).  The newly 
collected Virginia environmental isolate was identified as V. vulnificus. 
 
 Antibiotic Resistance Analysis 
 A comprehensive survey of antibiotic resistance in V. vulnificus was conducted 
and it was found that drug panel selection in previous studies was highly variable (Table 
10). However, there were several antibiotics common to many studies, many of which are 
included in the CLSI M45-A2 recommendations for V. vulnificus. In this study the         
V. vulnificus isolates exhibited little resistance to the 12 tested antibiotics (Appendix 
Tables A1-A4). None of the oyster, sediment, or water isolates were completely resistant 
to any of the tested antibiotics (Table 11, Appendix Tables A2, A3, and A4 respectively). 
A total of four isolates from humans, sediment, and water showed intermediate resistance 
to at least one antibiotic (Appendix Tables A1, A3, and A4 respectively). Interestingly, 
only two isolates, isolated from human blood, were fully resistant to one antibiotic: 














Table 10. Results of literature survey of antibiotic resistance studies conducted on V. 
vulnificus. A- color legend for antimicrobial classes, B- antimicrobial resistance results. 
A “1” indicates at least one isolate was resistant to the tested antibiotic while “0” 
indicates no isolates were resistant. “Instances of resistance” are the total number of 
studies that had an isolate that was resistant to the tested antibiotic; “instances of use” are 
the total number of studies that included the antibiotic regardless of the isolate’s 











5 Dihydrofolate reductase inhibitor 
6 Sulfonamide 
7 MurA inhibitor 
8 Carbapenem 
9 Cephalosporin 1st gen 
10 Cephalosporin 2nd gen 
11 Cephalosporin 3rd gen 
12 Cephalosporin 4th gen 
13 Cephem 
14 Amphenicol 








































































































































































































































































































































































 Antibiotic                           
                            





1 penicillin 0 1 0 0 1 1 0  1  1    1     1     7 
1
1 
1 carbenicillin 0   0 0 1   1 0 1              3 7 
1 
piperacillin 
tazobactam                0   0   1 0  1 4 




(augmentin)                      1 0 1 2 3 
1 
ampicillin 
sulbactam              1  0      1   2 3 
1 amoxicillin     1          1          2 2 
1 piperacillin                   0   1   1 2 
1 methicillin           1              1 1 
1 ticarcillin                        1 1 1 
2 gentamicin 0   0 0 1 0 1  0 0 0   1 0  1 0 1  1 0 1 7 
1
7 
2 amikacin    0 0   1  0     1    1 1  1 0 1 6 
1
0 
2 streptomycin     1 1 0 0 1  0  0  1  0   1     5 
1
0 
2 kanamycin 1   0 0 1  1 1    0    0        4 8 
2 neomycin       0  1           0     1 3 
2 tobramycin     1              0      1 2 




2 netilmicin        1                 1 1 
3 tetracycline 0   0 1 1 0 1 0 0 0 0 0 1 1  1   1 0 1 0 0 8 
1
9 
3 oxytetracycline         1     1 1          3 3 
3 doxycycline         0            0    0 2 
3 minocycline          0         0      0 2 
4 nalidixic acid     1 1  0 0  0  0 1 1     1     5 9 






)    0   0  0  0  0 1 1 0  0  1 0 1 0 0 4 
1
4 
5 trimethoprim     1   1 0  0    1  1   1     5 7 
6 
sulfamethoxaz
ole        0 1  1      1   1     4 5 
6 
sulfadimethoxi
ne     1                    1 1 
6 sulphatriad           1              1 1 
6 sulfathiazole               1          1 1 
6 
sulphamethiazo
le           1              1 1 
6 sulfanilamide     1                    1 1 
6 sulphadiazine       0                  0 1 
6 sulfisoxazole 0                        0 1 
7 fosfomycin     1                    1 1 
8 imipenem         0 0  0   0 0   0 0  0 0  0 9 
8 meropenem         0      1    0 0  1 0  2 6 
8 ertapenem                       0  0 1 
9 cephalothin 0   0   0  1 0 0  0  1   1  1  1   5 
1
1 
9 cefazolin               1 0   0   1 1  3 5 
9 cephalexin                         0 0 
1
0 cefuroxime        1            1  1   3 3 
1
0 cefoxitin               1       1   2 2 
1





0 cefamandole          0               0 1 
1
0 cefotiam                   0      0 1 
1
0 cefmetazole                   0      0 1 
1
1 cefotaxime         0 0  0  1     0   1  0 2 7 
1
1 ceftazidime        1  1  0       0   1   3 5 
1




(moxalactam)          1         0      1 2 
1
1 cefoperazone          0         0      0 2 
1
1 cefditoren                   0      0 1 
1
1 cefpodoxime                   0      0 1 
1
1 ceftiofur        0                 0 1 
1








4 flumequine         0     1           1 2 
1
4 florfenicol                         0 0 
1




5 levofloxacin          0         0   1 0  1 4 
1
5 enrofloxacin       0          1     1   2 3 
1
5 novobiocin    0     1  1              2 3 






5 norfloxacin                    0 0   0 0 3 
1
5 moxifloxacin          0     1          1 2 
1
5 gatifloxacin          0         0      0 2 
1
5 lomefloxacin          0               0 1 
1




(pefloxacin)                         0 0 
1
6 colistin 1 1 1 1     1  0              5 6 
1
6 polymyxin  b     1  1  1           1     4 4 
1




7 azithromycin               1          1 1 
1
8 nitrofurantoin 0    1    0  0   1 1      0  0  3 8 
1
8 furazolidone                  0       0 1 
1
9 fusidic acid           1              1 1 
1




mpin 0    0   0 1                1 4 
2
1 clindamycin 1         1 1              3 3 
2







































1 1 83 33 21 18 19 31 
13




Table 11. Isolates, out of all 143 tested, that displayed any resistance to the tested 
antibiotics. Abbreviations are as follows: TZP-piperacillin-tazobactam, GM-
gentamicin, TE-tetracycline, MEM-meropenem, IPM-imipenem, SXT-trimethoprim-
sulfamethoxazole, FEP-cefepime, CRO-ceftriaxone, AM-amoxicillin, C-
chloramphenicol, AN-amikacin, CIP-ciprofloxacin. 
    Antibiotic 
Specimen # Source TZP GM TE MEM IPM SXT FEP CRO AM C AN CIP 
              
137 Blood S S S S S S S S S S I S 
237 Blood S S S S S S S S R S S S 
248 Blood S S S S S S R I S S S S 
170 Sediment S S S S S S S S I S S S 
13 Water S S S S S S S S S S S I 
 
DNA BASED ANALYSIS 
Multiplex PCR of vvhA and 16S  
 A multiplex PCR protocol and comparison of three gel electrophoresis buffers 
was conducted on confirmed V. vulnificus isolates. The purpose of the multiplex PCR 
was to amplify both the bacterial 16S gene and the vvhA gene, the latter being unique 
to V. vulnificus. This multiplex reaction was designed to accomplish several things: 
verify that DNA was present in the sample, indicate that PCR reactions were not 
inhibited, identify V. vulnificus, and allow for DNA bands in the gel to be removed 
for sequencing if desired.  Additionally, the PCR reaction conditions were optimized 
as were gel running conditions. 
 Tris acetate EDTA (TAE), tris borate EDTA (TBE), and sodium borate (SB) 
(Brody and Kern 2004) gel electrophoresis running buffers were compared based on 
their ability to separate high (16S 1500bp) and low (vvhA 205bp)  molecular weight 




both 16S and vvhA under initial conditions (Figure 2). However, vvhA appeared to be 
preferentially amplified as the 205bp band appeared brighter. 
 
Figure 2.  Initial multiplex PCR conditions. Agarose gel electrophoresis was 
conducted for 40min at 6.7V/cm on a 1.5% TBE gel. Confirmed V. vulnificus isolates 
2, 10, and 63 were used as both 16S and vvhA positive controls. E. coli and an 
unknown presumptively identified V. vulnificus isolate (153) were used as positive 
controls for 16S gene amplification and a negative control for vvhA amplification. 
 
 A buffer comparison using PCR product from the initial multiplex PCR 
conditions was performed and all samples were run at 6.7V/cm for 30min (Figure 3 
A, B, and C). Both TAE and TBE were able to separate out the high molecular weight 
(16S) product with good resolution. SB appeared to cause smearing of the 16S 
product, this effect was repeatable (data not shown). Both TBE and SB, to a greater 
extent, were able to separate low molecular weight products with high resolution. 
Greatest band separation can be seen in SB at low molecular weights (Figure 3 C).  
 Reduction of vvhA primer concentration resulted in more even amplification 
relative to 16S amplification as determined by brightness (Figure 4 A). Additionally, 




similar trend was observed in that 16S resolution was highest in TAE and TBE; SB 
and TBE had greater vvhA separation, and high molecular weight smearing in SB was 
present (Figure 4 A, B, and C). 
  As MgCl2 concentration increased so did band intensity. However, at 3.5mM 
MgCl2 and above nonspecific amplification was present (Figure 5). The pattern for 
band resolution and separation remained unchanged at 5V/cm. A faint band in 
negative controls lanes was noted and determined to be from sample migrating into 
the empty well during gel preparation (data not shown) 
  
Application of Multiplex PCR 
Eight of the new presumptive V. vulnificus isolates (isolated from Virginia) 
were subjected to multiplex PCR to determine its effectiveness. The positive control 
(V. vulnificus isolate number 2) and one of the new environmental isolates tested were 
confirmed to be V. vulnificus as shown by the band at 205bp. All isolates had 
amplification of the 16S gene (band at 1500bp) (Figure 6). Species confirmation of 
isolates by vvhA PCR, according to Panicker and Bej (2005), had been conducted 








Figure 3.  Buffer comparison of TAE (A), TBE (B), and SB (C) at 6.7V/cm for 30min 
in 1.5% agarose gels. . Confirmed V. vulnificus isolates 2, 10, and 63 were used as 







V. vulnificus isolate (153) were used as positive controls for 16S gene amplification 






Figure 4.  Buffer comparison of TAE (A), TBE (B), and SB (C) at 10V/cm for 23min 







Confirmed V. vulnificus isolates 2, 10, and 63 were used as both 16S and vvhA 
positive controls. E. coli, an unknown presumptively identified V. vulnificus isolate 
(153), and V. parahaemolyticus (VP) were used as positive controls for 16S gene 






Figure 5. MgCl2 optimization with 1.5mM used as the control and increased to 2.5, 
3.5, and 4.5mM. Agarose gel electrophoresis was conducted at 5V/cm for 40min with 







2 and 10were used as both 16S and vvhA positive controls. V. parahaemolyticus (VP) 
was used as a positive control for the 16S gene amplification and a negative control 






Figure 6. Application of multiplex PCR to crude DNA extract. Agarose gel 
electrophoresis was conducted at 6.7V/cm for 30min in TBE. V. parahaemolyticus 
and E. coli were used as positive controls for 16S gene amplification and negative 
controls for vvhA amplification. Confirmed V. vulnificus isolate number 2 was used as 
a positive control for both 16S and vvhA amplification. The remaining isolates 270, 
279, 299, 303, 315, 317, 320, and 374 were presumptively identified as V. vulnificus 




Phylogenetic Analysis of vvhA 
 Phylogenetic analysis of the hemolysin A genes (vvhA) (~160bp with gaps 
and ~90bp without gaps) from 143 V. vulnificus isolates was conducted using the 
maximum likelihood and neighbor joining strategies. vvhA was used for analyses as it 
is unique to V. vulnificus (Wright et al. 1985), used to identify V. vulnificus (Panicker 
and Bej 2005),  and PCR product was available. Maximum likelihood analysis was 




used as it produces generally reliable trees much faster than maximum likelihood. To 
further test the reliability of each tree generated, bootstrapping of the dataset was 
employed. Analysis was conducted with Phylip V3.695 (Appendix Figures A1-A7) 
and MEGA V6.0 and portions of the vvhA gene from two isolates (VvMBC105and 
fj03-x2) from the NCBI database were included as references. A bootstrap percent of 
>70% was used to indicate a significant relationship (Hillis and Bull 1993). 
 Virulence data were provided by Dr. Moore and analysis was performed again 
using only MEGA V6.0. The effects of including or deleting all gaps in the 
sequences, when using maximum likelihood, or including all gaps or pairwise 
deletion, for neighbor joining, were compared. Keeping all gap sites created multiple 
subgroups with the maximum likelihood method (Figure 7 and sp9). Fewer branched 
groups were present when gaps were deleted (Figure 8 and sp10). However, several 
isolates and subgroups overlapped. The same trend was also present when alignments 
were constructed using MUSCLE when including all gaps (Figure 9 and sp11) and 
deleting all sites with gaps (Figure 10 and sp12). When all gaps were included in the 
analysis, all but one of the clinical isolates that associated with the environmental 
isolates, were grouped into two clusters: I and II (Figure 9 B and C)  However, more 
distinct sub groups were present  in the MUSCLE alignment compared to ClustalW2 
(Figures 7 and 9). Both maximum likelihood and neighbor joining trees produced by 
MEGA had two distinct branches and correlated with 16S type A and vcg type E 
(environmental) or 16S type B and vcg type C (clinical) no matter how the 
phylogenetic trees were constructed (typically a frequency of 99%). Virtually all 








Figure 7. Phylogenetic tree constructed using MEGA V6.0 maximum likelihood 
without deleting gaps and 1000 bootstrap replicates. ClustalW2 was used for 
sequence alignment. Bootstrap frequency (%) for main branches shown. Circled 
isolates represent environmental isolates on clinical branch or clinical isolates on the 
environmental branch.  Red: 16S type A/AB, vcg type E, pilF-, mannitol 
fermentation-; yellow: 16S type B, vcg type E, pilF+, mannitol fermentation+; blue: 
16S type does not match vcg type. Correction to isolate 141, it is listed as 141_C_H 












Figure 8. Phylogenetic tree constructed using MEGA V6.0 maximum likelihood, 
1000 bootstrap replicates, and all gap sites were deleted. ClustalW2 was used for 
sequence alignment. Bootstrap frequency (%) for main branch shown. Circled isolates 
represent environmental isolates on clinical branch or clinical isolates on the 
environmental branch.  Red: 16S type A/AB, vcg type E, pilF-, mannitol 
fermentation-; yellow: 16S type B, vcg type E, pilF+, mannitol fermentation+; blue: 
16S type does not match vcg type.  Correction to isolate 141, it is listed as 141_C_H 



























Figure 9. A: Phylogenetic tree constructed using MEGA V6.0 maximum likelihood 
without deleting gaps and 1000 bootstrap replicates. MUSCLE was used for sequence 
alignment, B: subgroup I, and C: subgroup II. Bootstrap frequency (%) for main 
branch shown in A and for sub branches B and C. Circled isolates represent 
environmental isolates on clinical branch or clinical isolates on the environmental 
branch.  Red: 16S type A/AB, vcg type E, pilF-, mannitol fermentation-; yellow: 16S 
type B, vcg type E, pilF+, mannitol fermentation+; blue: 16S type does not match vcg 
type. Names are as follows: isolate number, source type clinical (C) or environmental 
(E), isolate origin water (W), human (H), sediment (S), or oyster (O) 16S type A 
(environmental) or B (clinical) or AB, vcg type E or C, pilF polymorphism +/-, and 
mannitol fermentation +/-. Groups I and II contain most of the clinical isolates present 
on the environmental branch. Correction to isolate 141, it is listed as 141_C_H and 









Figure 10. Phylogenetic tree constructed using MEGA V6.0 maximum likelihood, 
1000 bootstrap replicates, and all gap sites deleted. MUSCLE was used for sequence 
alignment. Bootstrap frequency (%) for main branch shown. Circled isolates represent 
environmental isolates on clinical branch or clinical isolates on the environmental 
branch.  Red: 16S type A/AB, vcg type E, pilF-, mannitol fermentation-; yellow: 16S 
type B, vcg type E, pilF+, mannitol fermentation+; blue: 16S type does not match vcg 
type. Correction to isolate 141, it is listed as 141_C_H and should be 141_E_W. 
 
 Neighbor joining trees constructed using pairwise deletion of gap sites (Figure 
11 and sp13) appeared markedly different from those with all gap sites deleted 
(Figure 12 and sp14). Very few distinct sub groups were present in the neighbor 
joining tree where all gap sites were deleted and most isolates were considered 
equally related to each other (Figure 12). This was not the case when pairwise 






environmental isolates, as has been demonstrated in previous phylogenetic trees, 
numerous sub groups were created. All of the clinical isolates, present on the 
environmental side of the tree formed two clusters in the neighbor joining tree (Figure 
11 B. and C). When MUSCLE was used to align sequences the effect of gap deletion 
was very pronounced and varied. Again, complete deletion of gap sites resulted in 
few sub groups compared to pairwise deletion (Figure 13 and sp15 and Figure 14 and 
sp16 respectively). However, subgroups did not appear to correlate well between the 



























Figure 11. A: Phylogenetic tree constructed using MEGA V6.0 neighbor joining, 
2000 bootstrap replicates, and pairwise deletion of gap sites. ClustalW2 was used for 
sequence alignment, B: subgroup I, C: subgroup II. Bootstrap frequency (%) for main 
branch shown for the whole tree in A and in sub branches B and C. Circled isolates 
represent environmental isolates on clinical branch or clinical isolates on the 
environmental branch.  Red: 16S type A/AB, vcg type E, pilF-, mannitol 
fermentation-; yellow: 16S type B, vcg type E, pilF+, mannitol fermentation+; blue: 
16S type does not match vcg type. Names are as follows: isolate number, source type 
clinical (C) or environmental (E), isolate origin water (W), human (H), sediment (S), 
or oyster (O) 16S type A (environmental) or B (clinical) or AB, vcg type E or C, pilF 
polymorphism +/-, and mannitol fermentation +/-. Groups I and II contain clinical 
isolates that were associated with the majority of environmental isolates. Correction 




Figure 12. Phylogenetic tree constructed using MEGA V6.0 neighbor joining, 2000 
bootstrap replicates, and deletion of all gap sites. ClustalW2 was used for sequence 
alignment. Bootstrap frequency (%) for main branch shown. Circled isolates represent 






branch.  Red: 16S type A/AB, vcg type E, pilF-, mannitol fermentation-; yellow: 16S 
type B, vcg type E, pilF+, mannitol fermentation+; blue: 16S type does not match vcg 




Figure 13. Phylogenetic tree constructed using MEGA V6.0 neighbor joining, 2000 
bootstrap replicates, and deletion of all gap sites. MUSCLE was used for sequence 
alignment. Bootstrap frequency (%) for main branch shown.  Circled isolates 
represent environmental isolates on clinical branch or clinical isolates on the 
environmental branch.  Red: 16S type A/AB, vcg type E, pilF-, mannitol 
fermentation-; yellow: 16S type B, vcg type E, pilF+, mannitol fermentation+; blue: 
16S type does not match vcg type.  Correction to isolate 141, it is listed as 141_C_H 









Figure 14. Phylogenetic tree constructed using MEGA V6.0 neighbor joining, 2000 
bootstrap replicates, and pairwise deletion of gap sites. MUSCLE was used for 
sequence alignment. Bootstrap frequency (%) for main branch shown.  Circled 
isolates represent environmental isolates on clinical branch or clinical isolates on the 
environmental branch.  Red: 16S type A/AB, vcg type E, pilF-, mannitol 
fermentation-; yellow: 16S type B, vcg type E, pilF+, mannitol fermentation+; blue: 
16S type does not match vcg type. Correction to isolate 141, it is listed as 141_C_H 
and should be 141_E_W. 
 
 
Gap treatment substantially altered grouping of isolates within the clinical and 
environmental branches. Deletion of sites with gaps resulted in reduced branching of 
trees in general and different groupings of isolates. However, some subgroups 
overlapped between gap treatments.  Location of isolate origin did not appear to 






also associated with the constructed phylogeny, 16S, and vcg types.  The tested 
alignment strategies had some effect on tree topology. Regardless of the differences 
with alignment or tree construction strategy the same set of 11 clinical isolates 
appeared on the environmental side of all tested phylogenetic trees (Figures 7-14) 
(Table 12). Also, the same set of 13 environmental isolates appeared on the clinical 
origin branch (Table 13).  The five isolates not correctly identified by Biolog MIS did 
not appear to be grouped separately from other isolates. Including gaps generally 
resulted in increased sub branching but low bootstrap values (typically <70%) were 
obtained for each branch 
 
Table 12. Clinically acquired isolates that grouped with the majority of environmental 
isolates regardless of alignment algorithm or phylogenetic tree construction strategy. 
Names are as follows: isolate number, source type clinical (C) or environmental (E), 
isolate origin water (W), human (H), sediment (S), or oyster (O) 16S type A 
(environmental) or B (clinical) or AB, vcg type E or C, pilF polymorphism +/-, and 
mannitol fermentation +/-. 
Isolate Infection Type location 
   
249_C_H_B_E+- Septicemia Florida  
135_C_H_AB_E -- Septicemia Florida/Louisiana 
98_C_H_A_E+- Cutaneous Texas 
229_C_H_B_C++ Cutaneous Texas 
117_C_H_AB_E-- Unknown Texas 
140_C_H_A_E-- Septicemia Texas 
143_C_H_B_E+- Septicemia Texas 
148_C_H_A_E-- Septicemia Texas 
226_C_H_B_C++ Septicemia Texas 
227_C_H_A_E-- Septicemia Texas 









Table 13. Environmentally acquired isolates present on the clinical branch of all 
phylogenetic trees with isolate origin. Names are as follows: isolate number, source 
type clinical (C) or environmental (E), isolate origin water (W), human (H), sediment 
(S), or oyster (O) 16S type A (environmental) or B (clinical) or AB, vcg type E or C, 





















Media Comparison  
 Differential and selective media offer rapid low cost screening of samples for 
Vibrio isolates. In this study, the ability of several media to presumptively identify V. 




vulnificus followed by additional verification (FDA BAM 2013). This medium selects 
through high pH and a single carbon source: cellobiose. While all confirmed V. 
vulnificus isolates grew as yellow colonies on VVA in this study, i.e. it was effective 
at supporting V. vulnificus growth, when environmental isolations were performed it 
was shown not to be effective as a selective medium as numerous false positives were 
present.  CPC+ was developed to better reduce background flora and enhance           
V. vulnificus recovery by adjusting the concentrations of antibiotics (colistin and 
polymyxin B) and salts (Warner and Oliver 2007). When Jones et al. (2013) 
compared the ability of VVA and CPC+ to isolate V. vulnificus for enumeration as 
well as for preferential isolation of virulent genotypes no difference was observed. 
While less background flora grows on CPC+, numerous false positives can occur. To 
determine if CAV, which can differentiate several species of Vibrio, is more effective 
than CPC+ at isolating V. vulnificus and reducing false positives, Williams et al. 
(2013) used each to isolate V. vulnificus from the environment. Both media had 
numerous false positives when V. vulnificus numbers were low, similar to results in 
this study. Williams et al. (2013) demonstrated that CAV was able to differentiate V. 
alginolyticus, which appeared as white on CAV, from V. vulnificus (turquoise). Some 
strains of V. alginolyticus have the ability to ferment cellobiose which results in a 
false positive on CPC+ (Williams et al. 2013). In this study numerous isolates, shown 
not to be V. vulnificus by PCR, were presumptively identified as V. vulnificus on both 
VVA and CPC+, presumably due to their ability to ferment cellobiose. Very few, 
however, produced turquoise colonies on CAV (Table 10). Thus while these media 




vulnificus. To reduce the need for multiple steps and costs, Williams et al. (2013) 
developed a triple plating method in which environmental samples were plated on 
CAV and presumptive V. vulnificus colonies (turquoise) were then plated onto CPC+ 
and TCBS. If colonies appeared as yellow and green on CPC+ and TCBS 
respectively, they had a 93% probability of being V. vulnificus (Williams et al. 2013). 
However, when the triple plating method was tested by Froelich et al. (2014) only 
68% of isolates were correctly identified. The difference was attributed to a sub 
population of sucrose fermenting V. vulnificus. In this study ~17% of the previously 
confirmed isolates were able to ferment sucrose on TCBS, the same proportion as the 
study by Froelich et al. (2014). However, all of the isolates grew on TCBS in contrast 
to 23% of isolates that failed to grow on TCBS in Froelich et al. (2014). 
  Due to the ability of VVA to presumptively identify all of the known isolates 
(confirmed by PCR), it was used as the initial isolation media for environmental 
water samples. Yellow colonies were picked and subjected to media comparison as 
well as PCR verification. The majority of all 82 isolates collected during this study 
appeared as yellow colonies on VVA, TCBS, and CPC+ while white on CAV; none 
of which were identified as V. vulnificus by PCR. It is unusual such a high number of 
non V. vulnificus isolates were able to grow in the presence of colistin and polymyxin 
B in CPC+ agar. It is probable that by using VVA as the initial isolation medium that 
bacteria with similar traits to V. vulnificus were selected for, resulting in a high 
number of false positives. CAV was the most selective medium with very few isolates 
being presumptively identified, in contrast to the other media, on which most of the 




colistin and polymyxin B could be added (or increased if present) to CAV to increase 
its selectivity even further but testing would be needed. Due to PCR confirming only 
a single isolate, which had the characteristic media profile,  it can be concluded that 
CAV is a superior initial isolation medium as the fewest isolates grew with the V. 
vulnificus color, i.e. it produced the fewest false positives. High numbers of false 
positives from isolation increase the amount of downstream work, decrease 
efficiency, and increase cost. Therefore, use of CAV as the initial isolation medium 
followed by plating onto the other media, as in Williams et al. (2013), may provide a 
better path for screening samples. Use of VVA may be most useful as a routine 
growth medium for known VV isolates. 
 
Biolog Microbial Identification System  
 Identification of species can be performed using a variety of methods such as 
amplification of unique genes (e.g. vvhA) or sequencing of 16S fragments. 
Identification of isolates by PCR is considered the gold standard as a target gene that 
is unique to a species can be amplified. However, phenotypic approaches have been 
developed to identify isolates without the need for molecular analysis, and may also  
generate additional information. Biolog MIS uses unique substrate utilization profiles 
to determine the identity of an isolate. Similarly to Biolog MIS, API 20E and 20NE 
tests use substrate utilization to resolve species identity. A potential problem with 
identifying V. vulnificus using these methods is the phenotypic diversity and plasticity 
of the species (Harwood et al. 2004). Multiple studies have utilized each of the three 




was unable to identify any V. vulnificus isolates in two comparisons (Sanjuán et al. 
2009; Fouz et al. 2006). Biolog MIS GN (100%) (Fouz et al. 2006) and Generation II 
Microplates (84%) (Sanjuán et al. 2009) proved to be as good as or better than API 
20E (60-100% correct identification) when compared.  
Three V. vulnificus biotypes exist and differentiation of biotypes can be 
problematic due to metabolic differences. Sanjuán et al. (2009) found no correlation 
between phenotype and isolate origin, biotype, or serovar. In this study Biolog 
Generation III Microplates™ were used and 96% of isolates were correctly identified, 
suggesting this method can be an effective, accurate phenotypic test for V. vulnificus. 
Misidentification or no identification of the five isolates, in this study, may have been 
due to variation within the species. P. damselae appeared as the identity, or most 
probable identity, of two confirmed V. vulnificus isolates in this study. Vandenberghe 
et al. (2003) differentiated Vibrio into different phenotypic groups/species and found 
that V. vulnificus was related to Vibrio harveyi and Vibrio aestuarianus but not 
Photobacterium damselae. However, upon examination of the phylogenetic trees 
constructed in this study, these five isolates did not appear unique. While expensive 
(approximately $10 per isolate), Biolog MIS is a relatively simple, standardized 
method which also provides more information than just species identification. 
Metabolic profiles of isolates can be compared and used for further analysis.  
 
Antibiotic Resistance Analysis  
 Antibiotic susceptibility testing of V. vulnificus is important for monitoring of 




information on exposure to antibiotics in various environments. Generally few 
isolates have been resistant to agents recommended for treatment (Table 3). However, 
antibiotic resistance appears to be widespread but incredibly variable (Table 3). In 
this study 143 isolates were tested for resistance to 12 antibiotics and only two, out of 
58 isolates isolated from clinical samples, displayed complete resistance to a single 
antibiotic (cefepime or amoxicillin).  Three isolates, one of clinical and two of 
environmental origin, exhibited intermediate resistance to a single antibiotic 
(amoxicillin, amikacin, or ciprofloxacin), none of which are used for treatment of 
infections in humans (Appendix Table A1).  Location of isolation as well as local 
agriculture/aquaculture has been implicated in some antibiotic resistance variability. 
Kitiyodom et al. (2010) observed frequent resistances to tetracycline, 
fluoroquinolone, and sulfonamides in isolates from farmed shrimp, all of which are 
used heavily as prophylactics on local shrimp farms.  
 Antibiotic resistance profiling of V. vulnificus from oysters has been 
conducted for safety concerns and to determine if there is a difference in antibiotic 
resistance between isolates found in oysters or in water. Han et al. (2007) tested 
oysters from Louisiana and found that all V. vulnificus isolates (n=151) were 
susceptible to ampicillin while ~20% of V. parahaemolyticus isolates were 
susceptible. In contrast Okoh and Igbinosa (2010) found that all (18 isolates) tested V. 
vulnificus in South Africa were resistant to ampicillin and sulfamethoxazole, as have 
others (Table 12). Ottaviani (2001) isolated several antibiotic resistant and multidrug 
resistant  V. vulnificus  strains that produced ẞ-lactamase and several isolates were 




resistance to several classes of antibiotics was more common in environmental (n=14) 
V. vulnificus compared to oysters (n=17). However, a larger sample size is needed to 
be more definitive. Shaw et al. (2014) reported that few V. vulnificus (21/120) were 
resistant to any of the antibiotics tested. Interestingly, they noted that intermediate 
resistance to many of the tested antibiotics was common in contrast to the results of 
this study. 
 Treatment of patients with antibiotic resistant V. vulnificus infections can be 
complicated. V. vulnificus infections progress rapidly and an effective treatment plan 
must be implemented quickly before the patient is overwhelmed and dies (Oliver 
2013). Ciprofloxacin and cefotaxime have been reported to work synergistically to 
kill V. vulnificus in vitro more effectively than doxycycline and cefotaxime (the 
currently recommended treatment) (Kim et al. 2005). More recently, Jang et al. 
(2014) determined that the synergy worked in vivo to decrease mortality of mice. 
Ciprofloxacin also significantly (P<0.05) reduced transcription of the exotoxin 
repeats-in-toxin (RtxA1) analog PrtxA1. It was believed that suppression of RtxA1, 
which is involved in organ damage during sepsis, decreased the mortality rate (Jang et 
al. 2014). However, with antibiotic resistance a real concern and on the rise, it is 
likely that strains resistant to therapeutic drugs will emerge more frequently. An 
alternate strategy is to utilize bacteriophages to treat infections. Jun et al. (2014) 
demonstrated that phage therapy was able to prevent mouse mortality when 
challenged with a lethal dose of a multi-drug resistant pandemic strain of V. 




 Due to the low numbers of resistant organisms, no correlation between source 
(clinical or environmental) or isolate origin (human, oyster, sediment, or water) and 
antibiotic resistance could be made in this study. However, increasing the number of 
antibiotics may identify resistance to other antimicrobials and allow for better 
comparisons to be made. The 12 antibiotics used in this study were of medical 
importance for treatment, which is useful for public health. This study found that over 
a range of geographic locations and sources V. vulnificus isolates exhibited little 
resistance to common antibiotics, implying antibiotic treatment may still be an 
effective protocol for V. vulnificus infections, if the infection is identified quickly. 
However, including antibiotics that are common in agriculture (farm runoff) and 
aquaculture may provide additional perspective. Continued monitoring of resistance 
in V. vulnificus will be important in identifying increases in resistance and appropriate 
treatments.      
 
MULTIPLEX PCR OF vvhA AND 16S OPTIMIZATION 
 Multiplex PCR allows for amplification of multiple target genes at the 
same time. Various multiplex PCR protocols have been developed to identify V. 
vulnificus and determine its genotype. Several multiplex protocols have been 
developed to differentiate potentially pathogenic Vibrio spp. Bauer and Rørvik (2007) 
differentiated V. parahaemolyticus, V. cholerae, and V. vulnificus based on their toxR 
gene polymorphisms. However, some V. alginolyticus isolates yielded a false positive 
for V. parahaemolyticus. They developed a multiplex protocol specific for V. 




limited to biotype 1 only (Warner and Oliver 2008). In this study a novel multiplex 
PCR was created to amplify the 16S gene and a portion of the vvhA gene which can 
be used to identify V. vulnificus. The purpose of the multiplex PCR reaction was to 
validate the reaction and ensure no inhibitors were in the DNA sample by 
amplification of the 16S gene and test it in a real world scenario. This method has the 
advantage over standard PCR (Panicker and Bej 2005) in that it not only identifies the 
species as V. vulnificus, but it has a built in positive control, and if desired, bands can 
be removed from the gel for sequencing. 
 Several types of buffers have been created to improve band resolution as 
well as reduce costs. The three buffers (tris acetate EDTA, tris borate EDTA, and 
sodium borate)  compared in this study appeared to perform differently with respect 
to voltage and fragment size. TAE provided the highest band resolution with the 16S 
fragment, SB proved to be the best at separating low molecular weight fragments, and 
TBE was overall the best as it provided good separation and resolution of high and 
low molecular weight fragments. A similar trend was observed by Brody and Kern 
and it was shown that SB was able to maintain resolution of high molecular weight 
products at very high (350V) voltages (Brody and Kern 2004).  
 Voltage did not appear to have a large effect on band resolution with the 
tested buffers and PCR products. TBE appeared retain the highest overall separation 
at 6.7V/cm. However, the same pattern of separation based on buffer type was still 
present at all voltages tested. The ability to run at high voltage without sacrificing 
resolution is important to save time. Based on these results, TAE appears to be best 




molecular weight fragments. Other buffers have been proposed to further enhance 
band resolution at very low (<100bp) molecular weights such as 1mM lithium boric 
acid which was able to achieve 1bp resolution (Brody et al. 2004). Each type of 
buffer has unique characteristics and can be chosen based on cost, fragment size, 
voltage, and duration of electrophoresis to optimize band separation. 
 
PHYLOGENETIC ANALYSIS 
 In this study a short fragment (~90-160bp) of the vvhA gene, obtained from 
species identification PCR, from 143 isolates was sequenced. vvhA was used for 
analysis as it is used to identify V. vulnificus, unique to V. vulnificus, and PCR 
product was available from identification assays.  Two programs PHYLIP V3.695 
and MEGA V6.0 were used to help determine the phylogeny of the isolates. PHYLIP 
has been used for small datasets but as the number of sequences increases the time 
required to complete the processing quickly becomes overwhelming. MEGA is able 
to save time by using a modified version of maximum likelihood that reduces the 
computational burden (Tamura et al. 2011). A faster method, neighbor joining, was 
included to compare with the maximum likelihood method. In addition to comparing 
strategies for constructing phylogenies, two different sequence alignment strategies 
were compared: ClustalW2 and MUSCLE. The effects of gap treatment were also 
explored. 
 Several genes have been found to correlate with clinical and environmental 
strains of V. vulnificus and have been used to determine the pathogenic potential of 




PCR version by Vickery et al. 2007) and vcg type (E/C) have been well correlated 
with virulence and putative virulence factors including pilF polymorphism (Baker-
Austin et al. 2009). Rosche et al. (2005) correlated vcg type (E/C) with differences in 
vvhA between clinical and environmental isolates as well the number of copies of a 
heptanucleotide repeat. Additional correlations have been drawn with box PCR 
(Staley et al. 2011), RAPD PCR, housekeeping genes, and vvhA (Rosche et al. 2005; 
Rosche et al. 2010) among others. Rosche et al. (2010) reported that the differences 
between clinical and environmental isolates were present in the housekeeping genes 
recA and glnA but the differences were more pronounced in the virulence gene vvhA. 
Such differences could indicate a deep divide between strains. This difference was 
observed with the fragment of the vvhA gene used in this study. Both maximum 
likelihood and neighbor joining trees produced by MEGA had two distinct branches 
and correlated with 16S type A and vcg type E (environmental) or 16S type B and vcg 
type C (clinical) no matter the alignment algorithm (typically a frequency of 99%).  
The environmental isolates that were found on the clinical branch may 
represent pathogenic strains. Despite the observed differences with gap treatment, 
alignment algorithm, and tree construction method, low bootstrap values were 
obtained for almost all sub branches (data not shown). This could be due to the 
conserved nature of the vvhA gene and that a short sequence length was used for 
analysis.  Further analysis of the entire vvhA or 16S gene may lead to more 
associations between the previously mentioned virulence indicators and origin. 
Additionally, with a longer sequence the effects of tree construction strategy could 





 In this study a group of 143 clinical and environmental isolates were 
characterized using different phenotypic and genotypic approaches. Media profiles 
(colony color on selective or differential media) of the confirmed isolates, mostly 
matched those characteristic of V. vulnificus. Most of the tested media had very high 
false positive rates with the new presumptive V. vulnificus isolates from Virginia but 
CAV was determined to have the fewest false positives. Biolog Microbial 
Identification System, correctly identified 96% of the confirmed V. vulnificus isolates 
and was determined to be an accurate method for identification of V. vulnificus 
species. Approximately 9% of the clinical isolates and ~1% of the environmental 
were able to ferment sucrose (yellow appearance on TCBS). However, no other 
associations were found between colony color on the tested media and isolate origin.  
Almost all the V. vulnificus isolates were susceptible to all the antibiotics used (only 
five isolates displayed any type of resistance) and thus no relationship with origin 
could be established. A multiplex PCR protocol was developed, optimized, and tested 
to identify an isolate as V. vulnificus and include a positive control by amplification 
of vvhA (Panicker and Bej 2005) and the 16S (Fierer and Jackson 2006) gene 
respectively. Buffer optimization was simultaneously conducted with the multiplex 
PCR and TBE was determined to be the best buffer of those tested, for gel 
electrophoresis with the produced amplicons. Finally, phylogenetic analysis of the 
vvhA gene resulted in phylogenetic trees with two distinct branches related to clinical 
or environmental isolate origin. Virulence factors associated with clinical or 




study was conducted to further characterize a group of well studied V. vulnificus 
isolates and to find methods to differentiate clinical from environmental isolates. 
Continued analysis of these and additional isolates may further our knowledge of the 










































Antibiotic Resistance Analysis 
Table A1. Antibiotic resistance profiles of clinical isolates (obtained from human 
samples). Isolates that displayed an intermediate resistance are yellow and full 
resistances are red. 
    Antibiotic 
Specimen 
# 
Source TZP GM TE 
ME
M 
IPM SXT FEP CRO AM C AN CIP 
              
87 Blood S S S S S S S S S S S S 
91 Blood S S S S S S S S S S S S 
92 Blood S S S S S S S S S S S S 
93 Blood S S S S S S S S S S S S 
95 Blood S S S S S S S S S S S S 
96 Blood S S S S S S S S S S S S 
117 Blood S S S S S S S S S S S S 
123 Blood S S S S S S S S S S S S 
124 Blood S S S S S S S S S S S S 
126 Blood S S S S S S S S S S S S 
127 Blood S S S S S S S S S S S S 
130 Blood S S S S S S S S S S S S 
131 Blood S S S S S S S S S S S S 
133 Blood S S S S S S S S S S S S 
134 Blood S S S S S S S S S S S S 
135 Blood S S S S S S S S S S S S 
137 Blood S S S S S S S S S S I S 
210 Blood S S S S S S S S S S S S 
212 Blood S S S S S S S S S S S S 
213 Blood S S S S S S S S S S S S 
214 Blood S S S S S S S S S S S S 




216 Blood S S S S S S S S S S S S 
217 Blood S S S S S S S S S S S S 
218 Blood S S S S S S S S S S S S 
219 Blood S S S S S S S S S S S S 
220 Blood S S S S S S S S S S S S 
221 Blood S S S S S S S S S S S S 
222 Blood S S S S S S S S S S S S 
224 Blood S S S S S S S S S S S S 
225 Blood S S S S S S S S S S S S 
226 Blood S S S S S S S S S S S S 
227 Blood S S S S S S S S S S S S 
230 Blood S S S S S S S S S S S S 
231 Blood S S S S S S S S S S S S 
235 Blood S S S S S S S S S S S S 
236 Blood S S S S S S S S S S S S 
237 Blood S S S S S S S S R S S S 
238 Blood S S S S S S S S S S S S 
240 Blood S S S S S S S S S S S S 
248 Blood S S S S S S R I S S S S 
249 Blood S S S S S S S S S S S S 
250 Blood S S S S S S S S S S S S 
251 Blood S S S S S S S S S S S S 
252 Blood S S S S S S S S S S S S 
255 Blood S S S S S S S S S S S S 
257 Blood S S S S S S S S S S S S 
260 Blood S S S S S S S S S S S S 
261 Blood S S S S S S S S S S S S 



































S S S S S S S S S S S S 
 
 
Table A2. Antibiotic resistance profiles of isolates obtained from oysters. 
    Antibiotic 
Specimen 
# 
Source TZP GM TE 
ME
M 
IPM SXT FEP CRO AM C AN CIP 
              
101 Oyster S S S S S S S S S S S S 
104 Oyster S S S S S S S S S S S S 
110 Oyster S S S S S S S S S S S S 
113 Oyster S S S S S S S S S S S S 
114 Oyster S S S S S S S S S S S S 
115 Oyster S S S S S S S S S S S S 
 
 
Table A3. Antibiotic resistance profiles of isolates obtained from sediment. Isolates that 
displayed an intermediate resistance are in yellow. 
    Antibiotic 
Specimen 
# 
Source TZP GM TE 
ME
M 
IPM SXT FEP CRO AM C AN CIP 
























Table A4. Antibiotic resistance profiles of isolates obtained from water. Isolates that 
displayed an intermediate resistance are in yellow. 
    Antibiotic 
Specimen 
# 
Source TZP GM TE 
ME
M 
IPM SXT FEP CRO AM C AN CIP 
              
2 Water S S S S S S S S S S S S 
3 Water S S S S S S S S S S S S 
9 Water S S S S S S S S S S S S 
11 Water S S S S S S S S S S S S 
12 Water S S S S S S S S S S S S 
13 Water S S S S S S S S S S S I 
14 Water S S S S S S S S S S S S 
15 Water S S S S S S S S S S S S 
17 Water S S S S S S S S S S S S 
19 Water S S S S S S S S S S S S 
21 Water S S S S S S S S S S S S 
22 Water S S S S S S S S S S S S 
23 Water S S S S S S S S S S S S 
24 Water S S S S S S S S S S S S 
25 Water S S S S S S S S S S S S 
26 Water S S S S S S S S S S S S 
27 Water S S S S S S S S S S S S 
28 Water S S S S S S S S S S S S 
30 Water S S S S S S S S S S S S 
31 Water S S S S S S S S S S S S 
33 Water S S S S S S S S S S S S 
34 Water S S S S S S S S S S S S 
36 Water S S S S S S S S S S S S 
39 Water S S S S S S S S S S S S 
40 Water S S S S S S S S S S S S 
42 Water S S S S S S S S S S S S 
43 Water S S S S S S S S S S S S 
44 Water S S S S S S S S S S S S 
45 Water S S S S S S S S S S S S 
46 Water S S S S S S S S S S S S 
47 Water S S S S S S S S S S S S 
49 Water S S S S S S S S S S S S 
50 Water S S S S S S S S S S S S 
52 Water S S S S S S S S S S S S 




55 Water S S S S S S S S S S S S 
56 Water S S S S S S S S S S S S 
57 Water S S S S S S S S S S S S 
59 Water S S S S S S S S S S S S 
60 Water S S S S S S S S S S S S 
63 Water S S S S S S S S S S S S 
67 Water S S S S S S S S S S S S 
68 Water S S S S S S S S S S S S 
69 Water S S S S S S S S S S S S 
71 Water S S S S S S S S S S S S 
75 Water S S S S S S S S S S S S 
82 Water S S S S S S S S S S S S 
86 Water S S S S S S S S S S S S 
141 Water S S S S S S S S S S S S 
143 Water S S S S S S S S S S S S 
144 Water S S S S S S S S S S S S 
145 Water S S S S S S S S S S S S 
149 Water S S S S S S S S S S S S 
154 Water S S S S S S S S S S S S 
157 Water S S S S S S S S S S S S 
159 Water S S S S S S S S S S S S 
162 Water S S S S S S S S S S S S 
163 Water S S S S S S S S S S S S 
165 Water S S S S S S S S S S S S 
166 Water S S S S S S S S S S S S 
174 Water S S S S S S S S S S S S 
176 Water S S S S S S S S S S S S 
179 Water S S S S S S S S S S S S 
183 Water S S S S S S S S S S S S 
184 Water S S S S S S S S S S S S 
185 Water S S S S S S S S S S S S 
186 Water S S S S S S S S S S S S 
187 Water S S S S S S S S S S S S 
188 Water S S S S S S S S S S S S 
197 Water S S S S S S S S S S S S 
198 Water S S S S S S S S S S S S 
200 Water S S S S S S S S S S S S 
202 Water S S S S S S S S S S S S 









Maximum Likelihood: Dnamlk (Felsenstein 2013) 
 When using Dnamlk the following options were selected: for Global 
rearrangements yes was selected, Randomize input order was selected using 99 as a 
seed number and 7 as jumble number (when using bootstrapped data 3 was used as a 
seed and 2 for the jumble number, and Analyze multiple datasets was used with 100 




 Drawgram was used to view phylogenetic trees generated by Dnaml and 
Dnamlk.  
  
Neighbor Joining Step One: Dnadist (Felsenstein 2013) 
 The aligned sequence file was loaded into Dnadist. Default values were used 
except that multiple data sets was changed to yes and 100 data sets was entered 
  
Neighbor Joining Step Two: Neighbor (Felsenstein 2013) 
 To construct a neighbor joining tree, Neighbor was used with the file 




numbers and multiple data sets was changed to ‘yes’ for bootstrapped sequences with 
a value of 100.  
  
Bootstrapping with Seqboot and Consense (Felsenstein 2013) 
 To undergo resampling the alignment file was loaded into Seqboot. 
Ninetynine was used as the seed number and the default 100 replicates were used. 
Analysis was then conducted with Dnaml/Dnamlk/Dnadist and processed as before. 
Phylogenetic tree files were then loaded into Consense and the Majority rule was 
selected and then the phylogenetic tree was viewed with Drawgram. 
 
MEGA v6.0 
Sequence alignment and processing 
Trimmed sequences were imported and aligned using either ClustalW2 or 
MUSCLE. After alignment, gaps were present at the 5’ and 3’ ends so sequences 
were further trimmed to remove most of the gaps.   
   
Selecting a Proper Model 
 Sequence alignments were imported and Models was selected then Find Best 
DNA/Protein models (ML) was selected then protein coding DNA and analysis was 
run.  An output of recommended running parameters was then displayed. To compare 
the effect of using all sites/gaps versus deleting sites with gaps (complete deletion) 






Using the parameters outlined in the step above maximum likelihood analysis 
was conducted. Phylogeny> Construct/Test Maximum Likelihood Tree was selected 
and parameters were adjusted. One thousand bootstrap replications were used, 
complete deletion of gap sites; other options remained at default unless changed as 
recommended by Selecting the Proper Model or all sites were included.  
 
Neighbor Joining  
Under the Phylogeny tab Construct/Test Neighbor-Joining Tree was selected 
and all default values were used (Maximum Composite Likelihood, Complete 
Deletion of gaps etc.) except sequences had 2000 bootstrap replicates. To compare 
the effect of gap deletion both pairwise and complete deletion of gaps were used  
 
DISCUSSION 
PHYLIP was initially used for maximum likelihood analysis with a bootstrap 
size of 100 replicates. The program Dnamlk was run for 62hr on an AMD FX™-6300 
3.5GHz processor using seed numbers three and two (Figure A1, Figure SP2), an 
additional run using different seed numbers was attempted but did not complete after 
62hr. However, type B, or clinical isolates, tended to form subgroups away from type 
A, environmental, isolates (Figure A1 top half). Very little branching was present in 





 To compare methods, neighbor joining trees were constructed using PHYLIP. 
Each tree used different seed numbers for comparison. Three distinct groups were 
present, environmental/type A (I), clinical/type B (III), and both (II) (Figure A2, 
Figure SP3). Interestingly, the distinct clinical and environmental branches present in 
individual maximum likelihood trees (supplemental file P1) are more similar in 
topology to Figure A2 than the maximum likelihood consensus tree (Figure A1). To 
verify that the produced tree was accurate a second tree using different seed numbers 
was constructed (Figure A3, Figure SP4). No major change in topology between trees 
was noted and the same three branches were present (environmental/type A (I), both 
(II), and clinical/type B (III)).  
 Due to the large amount of time required to run the maximum likelihood 
analysis in PHYLIP, failure of some programs to finish, and distinct differences in 
tree topology, MEGA V6.0 was utilized. Maximum likelihood analysis was 
conducted again and two different alignment algorithms were used: ClustalW2 and 
MUSCLE. ClustalW2 alignment produced a tree with two distinct branches 
designated: clinical (left) and environmental (right) (Figure A4 and SP5). Six sub 
groups were present but did not appear to associate with any of the virulence factors 
or origin (Figure A4). Minor changes to grouping of a few isolates, between 
alignment strategies, was present (Figure A5 and SP6). 
 Again, neighbor joining trees were constructed to compare the two alignment 
strategies as well as tree constructing methods. Little difference between alignment 
strategies was found. More sub groups were present on the environmental (right side) 









Figure A1. Consensus phylogenetic tree of 145 vvhA genes constructed using Dnamlk 
with 100 bootstrapped replicates. Names are as follows: isolate number, source type 
clinical (C) or environmental (E), 16S type A (environmental) or B (clinical) or AB, 







Figure A2. Neighbor joining tree constructed using PHYLIP and 100 bootstrap 
replicates. Groups are separated by lines: environmental/type A (I), clinical/type B 
(III), and both (II).  Names are as follows: isolate number, source type clinical (C) or 
environmental (E), 16S type A (environmental) or B (clinical) or AB, and isolate 









Figure A3. Alternate neighbor joining tree constructed using PHYLIP and 100 
bootstrap replicates. Groups are separated by lines: environmental/type A (I), 
clinical/type B (III), and both (II). Names are as follows: isolate number, source type 
clinical (C) or environmental (E), 16S type A (environmental) or B (clinical) or AB, 













Figure A4. Phylogenetic tree constructed using MEGA V6.0 maximum likelihood method with 
1000 bootstrap replicates. ClustalW2 was used for sequence alignment. Sub-groups (I-VI) are 
separated by lines. Names are as follows: isolate number, source type clinical (C) or 
environmental (E), 16S type A (environmental) or B (clinical) or AB, and isolate origin water 











Figure A5. Phylogenetic tree constructed using MEGA V6.0 maximum likelihood method with 
1000 bootstrap replicates. MUSCLE was used for sequence alignment. Names are as follows: 
isolate number, source type clinical (C) or environmental (E), 16S type A (environmental) or B 










Figure A6. Phylogenetic tree constructed using MEGA V6.0 neighbor joining with 2000 
bootstrap replicates. ClustalW2 was used for sequence alignment. Names are as follows: isolate 
number, source type clinical (C) or environmental (E), 16S type A (environmental) or B 










Figure A7. Phylogenetic tree constructed using MEGA V6.0 neighbor joining with 2000 
bootstrap replicates. MUSCLE was used for sequence alignment. Names are as follows: isolate 
number, source type clinical (C) or environmental (E), 16S type A (environmental) or B 
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